Skip to content

Clinical study of autologous epidermal cell transplantation in the repair of extremely severe burn wounds

Clinical study of autologous epidermal cell transplantation in the repair of extremely severe burn wounds

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049599
Enrollment
Unknown
Registered
2021-08-06
Start date
2021-07-29
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe burns

Interventions

experimental group:Cell transplantation

Sponsors

Burn Department of the First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Voluntary and clinical treatment of patients with insufficient skin source; 2. The selected patients are voluntary and sign the "informed consent"; 3. Aged 18-60 years old; 4. Very severe burn patients: burn area >= 50% TBSA, and scalp burn patients.

Exclusion criteria

Exclusion criteria: 1. Patients with a clear history of malignant tumors, AIDS, autoimmune diseases, and organ transplantation; 2. Patients who are pregnant or breastfeeding; 3. Those who have had myocardial infarction and cerebrovascular accident within 6 months; 4. The investigator's comprehensive assessment believes that the patient and his family have poor willingness to treat, which may lead to the risk of trial termination; 5. The researcher comprehensively evaluates the possible situations related to the poor quality of life caused by scars after the patients and their families cannot receive successful treatment; 6. Patients with poor systemic condition, multiple organ failure, severe systemic infection and severe wound infection, etc., and the investigators comprehensively evaluate patients who believe that the condition is unstable or the wound has no ability to receive skin (it is believed that the wound cannot survive after cell transplantation); 7. Other conditions deemed inappropriate by the investigator.

Design outcomes

Primary

MeasureTime frame
re-epithelialization;Wound healing rate;Wound healing time;Time in BICU;Quality of wound healing;

Countries

China

Contacts

Public ContactZhan Rixing, Luo Gaoxing, Yu Shicang

the First Affiliated Hospital of Army Medical University

zhanrixing@sina.com+86 15823548250

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026